Manufacturer GlaxoSmithKline has voluntarily issued a recall for all of its non-prescription Alli weight loss products in the United States and Puerto Rico. The recall is due to concerns that the product packages may have been tampered with, and do not actually contain Alli.
Tablets and capsules that were not Alli have been reported in Alli bottles in seven states, and in some cases, bottles were missing labels and had fake tamper-evident seals. The tampered bottles were sold in retail stores.
Authentic Alli capsules are turquoise blue with a dark blue band, imprinted with “60 Orlistat.” The authentic bottle has a label and an inner foil seal imprinted with “Sealed for Your Protection.”
Tampered packaging may have an authentic-looking outer carton, but the bottle may not have a label; the seal may not be intact, made of foil, or have the correct imprint; and the bottle may contain tablets and capsules of various shapes and colors.
Some bottles from the following lots and expiration dates have been reported to contain products other than Alli:
- Lot 14372, expires 02/28/2016
- Lot 14395, expires 02/28/2016
- Lot 14124, expires 09/30/2015
- Lot 14267, expires 01/31/2016
- Lot 14442, expires 04/30/2016